reference/9213588

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9213588

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Clinical Trial, Phase I\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	3385
issn	1557-3265 1078-0432
issueIdentifier	10
pageRange	3377-3385
publicationName	Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage	3377
bibliographicCitation	Alexandre J, Raymond E, Kaci MO, Brain EC, Lokiec F, Kahatt C, Faivre S, Yovine A, Goldwasser F, Smith SL, MacDonald JR, Misset JL, Cvitkovic E. Phase I and pharmacokinetic study of irofulven administered weekly or biweekly in advanced solid tumor patients. Clin Cancer Res. 2004 May 15;10(10):3377–85. doi: 10.1158/1078-0432.ccr-03-0349. PMID: 15161692.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_522dccc1665fd50b6018b1890d4e4190 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f1c7899cb0ddc981fee0b3bc8f9d6872 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0b27f0ee55667902b05737c75aa06c10 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0aa998fb4ce4a0cd53dc6fd95e0dd888 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f74c379288344a3053219b22961befe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_97f5d1af386bb3f900b41cdd4a618a5c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a0371f0abc0635e1c2c3b0bba39ebfc1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1590-485X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_81b499fb13408507abe6025e882014b5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e155cdb0063ff48929ab078b090c36b6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c22462c6a2fcf2d6860f79bdcd48ae47 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_88f1dcf01932c51acd860dd8081ad259 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_161b9c6addae98e101bfefd9ca60ab94 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5c93503e370200a46f83feb06994404c
date	2004-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/15161692 https://doi.org/10.1158/1078-0432.ccr-03-0349
isPartOf	https://portal.issn.org/resource/ISSN/1078-0432 https://portal.issn.org/resource/ISSN/1557-3265 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Phase I and Pharmacokinetic Study of Irofulven Administered Weekly or Biweekly in Advanced Solid Tumor Patients
discusses	http://id.nlm.nih.gov/mesh/M0019703 http://id.nlm.nih.gov/mesh/M0028268 http://id.nlm.nih.gov/mesh/M0268775 http://id.nlm.nih.gov/mesh/M0001483
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000970Q000008 http://id.nlm.nih.gov/mesh/D012717Q000008 http://id.nlm.nih.gov/mesh/D009369Q000188 http://id.nlm.nih.gov/mesh/D018906Q000493
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D020714 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D013997 http://id.nlm.nih.gov/mesh/D000970Q000493 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D012717Q000493 http://id.nlm.nih.gov/mesh/D015331 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D004305
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9408 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148189 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID638015

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128684338 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135844626

Total number of triples: 61.